TipHub

₹552.65

▲ +5.25 +0.96%

As of 29 Jul 2026 · delayed

NSE Listed · Healthcare

Sai Parenteral's Limited (SAIPARENT)

Volume: 54,559Avg Vol 1W: 65,542Avg Vol 1M: 3,06,77552W Range:₹400₹706
NSE BSE www.saiparenterals.com AI Report
Key Ratios
Checked just now
Market Cap₹2,442 Cr
Current Price₹552.65
Previous Close₹547.4
High / Low (52w)₹706 / ₹400
Volume54,559
Avg Vol (1W)65,542
Avg Vol (1M)3,06,775
Stock P/E137.48
Book Value₹111.08
Dividend Yield0%
ROE290.54%
ROA45.64%
Revenue (TTM)₹381 Cr
Revenue Growth—
Profit Margin0%
Total Debt₹243 Cr
Shares Outstanding4 Cr
Face Value₹5
EPS (TTM)₹4.02
P/B4.98
Debt / Equity1.26
50 DMA₹556.11
200 DMA—
Day change+0.96%
Price Chart
₹552.65▲ 36.22% · 1Y
₹624₹40630.1L
2026-04-02
2026-07-29

20-day avg volume: 2.8L shares

Pros
  • Healthy return on equity of 290.5%.
  • Company is almost debt-free.
  • Revenue grew 48% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 137.
Quarterly Results
MetricDec 2025Mar 2026
Revenue₹96 Cr₹198 Cr
EBITDA₹-6 Cr₹21 Cr
Net Profit₹-7 Cr₹13 Cr
EPS——
Profit & Loss (Annual)
MetricMar 2023Mar 2024Mar 2025Dec 2025Mar 2026
Revenue₹97 Cr₹155 Cr₹164 Cr₹38 Cr₹57 Cr
EBITDA₹12 Cr₹24 Cr₹32 Cr₹3 Cr₹12 Cr
Net Profit₹4 Cr₹8 Cr₹14 Cr₹0 Cr₹10 Cr
EPS6.1610.545.43——
Balance Sheet
MetricMar 2023Mar 2024Mar 2025
Total Assets₹134 Cr₹268 Cr₹272 Cr
Total Liabilities₹102 Cr₹192 Cr₹177 Cr
Equity₹31 Cr₹76 Cr₹96 Cr
Total Debt———
Cash Flow
MetricMar 2023Mar 2024Mar 2025
Operating₹-10 Cr₹-30 Cr₹34 Cr
Investing₹-19 Cr₹-46 Cr₹0 Cr
Financing₹24 Cr₹79 Cr₹-36 Cr
Free Cash Flow₹-10 Cr₹-30 Cr₹34 Cr
Shareholding
Promoter 51.16% Institutions 12.56% Public 36.29%
About Sai Parenteral's Limited

Healthcare · Drug Manufacturers - General

Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company was founded in 1988 and is based in Hyderabad, India.

www.saiparenterals.com ↗
Efficiency & Working Capital
ROCE16.7%
Interest Coverage2.7
Dividend Payout—
Debtor Days283 d
Inventory Days114 d
Payable Days130 d
Cash Conversion Cycle268 d
Working Capital Days398 d
Shareholding Details

As of 2026-06-30

Promoter51.2%
FII4%
DII8.5%
Institutions12.6%
Public36.3%
Promoter Pledge0%
No. of Shareholders9,312
Shareholding Pattern

Quarterly — figures in %. Latest 7 quarters.

PeriodMar 2026Jun 2026Sept 2025Mar 2026Apr 2026Apr 2026Jun 2026
Promoters70.7%70.7%61.2%51.2%51.2%51.2%51.2%
FIIs——0%5.7%5.7%5.7%4%
DIIs——0%12.9%12.9%12.9%8.5%
Public20.9%20.9%38.8%30.3%30.3%30.3%36.3%
Promoter Pledge——0%0%0%0%0%
No. of Shareholders——1197,6877,6877,6879,312
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Vijitha GorrepatiShareholding of Promoter and Promoter Group28.9%1.28 Cr
Anil Kumar KarusalaShareholding of Promoter and Promoter Group10.3%45,58,597
Aruna KarusalaShareholding of Promoter and Promoter Group7.4%32,68,010
Bhaskara Rao BollineniPublic Shareholding4.6%20,13,488
Kunal KakumanuShareholding of Promoter and Promoter Group4.5%20,00,000
Samarsh Capital-samarsh Capital-fund IPublic Shareholding3.5%15,23,437
Kotak Mahindra Life Insurance Company Ltd.Public Shareholding2.4%10,40,328
Aig Direct LlcPublic Shareholding2.1%9,37,500
Agilis Partners LlpPublic Shareholding2.1%9,08,027
Kotak Life Sciences Fund IPublic Shareholding1.7%7,65,282
Nanda Govind BhattadPublic Shareholding1.7%7,35,000
Reina R JaisinghaniPublic Shareholding1.6%7,01,923
Sapna Sameer ShahPublic Shareholding1.5%6,75,000
Arihant Capital Markets LimitedPublic Shareholding1.4%6,15,926
Pooja Lakshmi DoppalapudiPublic Shareholding1.3%5,88,700
India Emerging Giants Fund LimitedPublic Shareholding1.3%5,89,466
Morgan Stanley Asia (singapore) Pte. - OdiPublic Shareholding1.2%5,14,798
Board of Directors
NameDesignationYear
ANIL KUMAR KARUSALAChairman / Executive Director / Managing Director2025
Vijitha GorrepatiE D & Wholetime Director2025
ARUNA KARUSALANon Executive Director2025
G S R AnjaneyuluIndependent Non Exe. Director2025
Bhagyashri Dharmasa ZadIndependent Non Exe. Director2025
Kalidindi V RajuIndependent Non Exe. Director2025
Shivali AggarwalCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹5211313
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500015015
202500013013
2025000202
Company Information
Incorporated2001
ChairmanANIL KUMAR KARUSALA
AuditorR Kabra & Co LLP
Investor Email[email protected]
🌐 www.saiparenterals.com ↗

📍 No.39 5th Flr Lavanya Arcade-, Jayabheri Enclave Gachibowli, Ranga Reddy, Telangana, 500032

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free
IPO History
IPOlisted · listed 2026-04-02

More stocks

Sahasra Electronic Solutions Ltd.Shalibhadra Finance Ltd.Sahyadri Industries Ltd.Sameera Agro And Infra LimitedSteel Authority of India Ltd.Sai Life Sciences LimitedSaj Hotels LimitedSakar Healthcare LimitedSakthi Sugars Ltd.Saksoft LimitedSakuma Exports LimitedSalasar Techno Engineering Ltd.All “S” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search